QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia? [electronic resource]
Producer: 20160628Description: 287-90 p. digitalISSN:- 1468-2044
- Adolescent
- Alendronate -- adverse effects
- Antineoplastic Agents -- therapeutic use
- Bone Density Conservation Agents -- adverse effects
- Diphosphonates -- adverse effects
- Female
- Humans
- Osteonecrosis -- chemically induced
- Pain -- drug therapy
- Pamidronate
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Risedronic Acid -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.